OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-11-30-accounts

Registered number: 01635916 Charity number: 284881

PENNY BROHN CANCER CARE

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2021

PENNY BROHN CANCER CARE

CONTENTS

Page
Reference and Administrative Details of the Charity, its Trustees and Advisers 1
Trustees' Report 2
Trustees' responsibilities statement 14
Independent Auditors' Report on the Financial Statements 15 - 18
Consolidated Statement of Financial Activities 19
Consolidated Balance Sheet 20
Charity Balance Sheet 21
Consolidated Statement of Cash Flows 22
Notes to the Financial Statements 23 - 43

PENNY BROHN CANCER CARE

REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 30 NOVEMBER 2021

Trustees Rev Dr Victor Barley2
Jessica Brohn
Rebecca Granger3
Jacqueline Graves2
Jonathon Green (appointed 21 October 2021)
Katherine Groombridge (resigned 21 October 2021)3
Ken Guy1
Alex Hamilton-Baily2
Pinelopi Kechagioglou (appointed 21 October 2021)
Stephen Rosser1,3
Charles Russell-Smith3
Mohammed Saddiq1
Charlotte White1
1
Finance & Audit Committee
2
Remuneration and Appointments Committee
3
Shop@PennyBrohn Ltd Director
Company registered
number
01635916
Charity registered
number
284881
Registered office
Chapel Pill Lane
Pill
Bristol
BS20 0HH
Company secretary
Gail Boulton
Chief executive officer
Julie Worrall
Independent auditors
Bishop Fleming LLP
Chartered Accountants
Statutory Auditors
10 Temple Back
Bristol
BS1 6FL

Page 1

PENNY BROHN CANCER CARE

TRUSTEES REPORT FOR THE YEAR ENDED 30 NOVEMBER 2021

Welcome to our 2021 Annual Report and Accounts for the period 1 December 2020 to 30 November 2021

The COVID-19 pandemic continued to challenge daily life throughout 2021, and through it all, Penny Brohn Cancer Care consistently supported people living with cancer through a hybrid programme of virtual and faceto-face services.

The capacity and scope of our weekly virtual services programme expanded, always seeking to provide trusted information, practical support, and a safe space for people with cancer. During the latter half of the year, we reintroduced limited face-to-face client services through Wellbeing Days held at our National Centre and individual therapies delivered at our retail Hub, with the safety of our clients always our top priority. We also continued delivering face-to-face services in medical settings via our partnerships.

Our income from hospitality and retail operations improved on 2020 values, despite the ongoing impact of national and local restrictions due to COVID-19. Fundraising income exceeded expectations, exemplified by an inspiring £80,000 gift from a generous anonymous donor and a strong year of legacy giving, with £475,000 ² received during 2021. We closed the year with a small surplus of £47,000 a striking achievement made possible by our dedicated staff and partners, valued clients, loyal supporters, and committed funders.

Led by CEO Julie Worrall, a working group representing a cross-VHFWLRQ�RI�WKH�&KDULW\¶V�VWDII�WHDP�FR-created an exciting new five-year organisational strategy for Penny Brohn Cancer Care. We consulted with and listened to the views of people with cancer, clinicians, our partners and supporters to inform its development. At the heart of this new strategy is the conviction that anyone with a cancer diagnosis; regardless of their cancer, prognosis, socioeconomic status, cultural background or where they live, should be able to access to safe and effective integrative cancer care and that Penny Brohn Cancer Care has a responsibility to play a leading role in bringing integrative cancer care into mainstream health provision to support equitable outcomes for all people with cancer. We will enable this by being a one-stop resource for people with cancer and their clinicians to access the best of clinical, lifestyle and evidence-based supportive therapies. We will set a standard for others to follow.

Thanks to the &KDULW\¶V�VWURQJ�ILQDQFLDO�SHUIRUPDQFH�LQ�������ZH�FDQ�QRZ�VWDUW�WR�LQYHVW�LQWR�WKH�GHOLYHU\�RI� our new strategy. Our reserves will also allow us to mitigate risk as we continue to live with the aftereffects of the pandemic.

This year, we also welcomed two new trustees, Dr Pinelopi Kechagioglou and Jonathon Green, to the Board. Pinelopi is a consultant clinical oncologist with a passion for digital health innovation. As co-chair of the British Society for Integrative Oncology (BSIO), she shares our vision to make integrative cancer care mainstream in the NHS. Jonathon is a former NHS hospital chief executive and offers a unique and informed perspective on how best to build integrative support services around cancer patients. We know the Charity will benefit enormously from their collective knowledge and experience.

We also said farewell to Kate Groombridge, who resigned from the Board in October. A former client, Kate has been a Trustee since March 2017. We wish Kate well and know she will continue to be a committed ambassador and advocate for the Charity in the future.

By 2035, 4 million people in the UK will be living with cancer. A quarter of these will also be living with the long-term physical or psychosocial impact of their cancer/treatment and will face significantly poorer quality of life. Despite an increasing number of people actively looking for ways to support themselves better, the lack of an accessible source of integrative cancer care provision in the UK means that they are not able to find the help they need. Penny Brohn Cancer Care, with its 40 years of experience, is well-positioned to become their main provider of accessible integrative support in the UK. We believe we have a responsibility to people with cancer to step into this space quickly to enhance quality of life and drive better outcomes for all adults living with cancer in the UK.

Stephen Rosser Chair

Page 2

PENNY BROHN CANCER CARE

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2021

The Trustees of Penny Brohn have pleasure in presenting their report and financial statements for the year ended 30th November 2021.

2XU�UHSRUW�LQFOXGHV�WKH�'LUHFWRU¶V�UHSRUW��7KH�ILQDQFLDO�VWDtements comply with the Charities Act 2011, Companies Act 2006, the Memorandum and Articles of Association and Accounting and Reporting by Charities; Statement of Recommended Practice applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland ((Charities SORP (FRS102)).

OUR ACHIEVEMENTS AND PERFORMANCE

The Highlights

Page 3

PENNY BROHN CANCER CARE

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2021

Key areas of focus in 2021-2022

1. Expanded the breadth of our services

³7KLV�FKDULW\�KDV�EHHQ�D�VKLQLQJ�OLJKW�LQ�ZKDW�KDV�EHHQ�D�GDUN�SODFH�IRU�PH��7KDQN�\RX�IRU�DOO�\RX�GR��<RX� PDNH�VXFK�D�GLIIHUHQFH�´

We continued to build and adapt our comprehensive programme of virtual support across digital platforms, including Zoom, YouTube, social media and our website. We optimised telephone and email for one-to-one support. The support provided is based on and around the needs for support that people with cancer shared with us.

This virtual programme focused on providing reassuring emotional and practical support, and reliable information, enhanced by our collaboration with sector experts in complementary, integrative, and nutritional medicine to deliver specialist sessions. 86% of those who we spoke to felt that they were able to better manage their own wellbeing as a result of our virtual programme, particularly valuing the knowledge and reassurance offered.

In addition we launched a new online Treatment Support Programme consisting of four weekly sessions, each focused on a different area of self-management education. Early evaluation of the programme has provided strong evidence that participants made positive lifestyle changes as part of their involvement, that their cancer-related concerns had been reduced and their wellbeing improved. 95% said they would recommend the Treatment Support Programme to others going through cancer treatment. The overall experience of taking part in the Treatment Support Programme was rated as 4.75/5.

Face-to-face services were delivered in conjunction with our partners in medical settings when restrictions allowed us to do so safely, and at our National Centre and Hub during the summer and autumn. Three pilot wellbeing days were held during 2021, a successful initiative that will now continue to 2022 alongside the return of overnight retreats.

We also reopened our beautiful National Centre and therapeutic gardens as a community space, including making available a twice weekly delicious and nutritious lunch.

2. Increased access to our support

³,¶P�EORZQ�DZD\�E\�WKH�ZRQGHUIXO�UHVRXUFHV�DW�D�WLPH�ZKHQ�,�IHHO�HYHU\WKLQJ�LV�GLIILFXOW�DQG�DJDLQVW�PH�DQG�QR� one understands how GLIILFXOW�WKLV�MRXUQH\�LV��7KDQN�\RX�´

During 2021 we developed our website, increasing the available content and improving the ability of people ZLWK�FDQFHU�WR�DFFHVV�WKH�YLWDO�UHVRXUFHV�WKH\�QHHG��2XU�ZHEVLWH¶V�UHVRXUFHV�VHFWLRQ�QRZ�FRPELQHV�H-books, PDFs, and webinars to create a one-stop shop of self-serve content that can be accessed at any time. Anybody can access information on wellbeing, nutrition, and exercise, as well as content relating to specific cancers (e.g. prostate and breast cancer). Daily visits to our website have doubled since 2020, with traffic to our online services page increasing by 130%.

We also partnered with Headspace and Big Health to offer free subscriptions to digital wellbeing tools Headspace, Sleepio (an evidence-based sleep support programme) and Daylight (an anxiety support app) to Penny Brohn Cancer Care clients. Almost 700 clients subscribed to these services.

Page 4

PENNY BROHN CANCER CARE

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2021

3. Increased presence in and understanding of the community we exist to serve

³0\�DELOLW\�WR�IO\�WKURXJK�FKHPR�UHODWLYHO\�XQVFDWKHG�LV�GRZQ�WR�3HQQ\�%URKQ�DQG�WKHVH�VHVVLRQV´

$V�SDUW�RI�RXU�&RPPXQLW\�(QJDJHPHQW�3URJUDPPH��IXQGHG�E\�7KH�3ULQFH�RI�:DOHV¶V�&KDULWDEOH�)RXQGDWLRQ�� we initiated six-month pilot collaborations with the Square Food Foundation, a Bristol based cookery school and community kitchen; and Toral Shah, a nutritional scientist and founder of the Urban Kitchen. The overarching objectives of both projects were to build our understanding of the needs of communities not historically reached by Penny Brohn Cancer Care and raise awareness among those communities of the VXSSRUW�DQG�VHUYLFHV�ZH�RIIHU��:H�DUH�FXUUHQWO\�FRPSOHWLQJ�DQG�HYDOXDWLQJ�WKHVH�SURMHFWV¶

:H�EHJDQ�D�SDUWQHUVKLS�ZLWK�%H2Q%RDUG��DOVR�VXSSRUWHG�E\�IXQGLQJ�IURP�7KH�3ULQFH�RI�:DOHV¶s Charitable Foundation, to support Penny Brohn Cancer Care in developing an integrated equality, diversity, and inclusivity (ED&I) framework and action plan. This work has been delivered through a series of training/coaching sessions designed to engage Trustees and staff, so that ED&I is baked into the Charity at DOO�OHYHOV��%H2Q%RDUG¶V�&(2�LV�.DOSQD�:RROI��DQ�DZDUG-winning former BBC Head of Production and founder of 91 Ways to Build a Global City, a charity which seeks to unite the 91 language communities of Bristol through food. Kalpna is a well-known and respected figure in the Bristol business community, and her knowledge and that of her team has already been invaluable to Penny Brohn Cancer Care.

The Penny Brohn Hub in Bristol City Centre opened in September 2020. A ten-minute walk from Bristol Oncology and Hematology Centre (BHOC), our financially self-sufficient Hub combines a boutique take on the traditional charity shop offering with access to cancer therapies in purpose-built therapy rooms. Therapy sessions were introduced at the Hub in September, including acupuncture, shiatsu, and reflexology.

4. Enhanced Partnership Working

³'XULQJ�WKH�PRVW�GLIILFXOW�SHULRG�LQ�P\�OLIH��,�FDQQRW�HPSKDVLV�HQRXJK�KRZ�EHQHILFLDO�WKHLU�VHUYLFH�ZDV�GXULQJ� that WLPH���,�KDYH�OHDUQW�D�ORW�DQG�ZLOO�WDNH�WKDW�NQRZOHGJH�ZLWK�PH�WR�VXSSRUW�P\�PHQWDO�ZHOOEHLQJ�LQ�WKH� IXWXUH�´

Penny Brohn Cancer Care and Genesis Care launched a partnership in 2013 with a shared vision to help people with cancer live the best life possiEOH��E\�SURYLGLQJ�PRUH�WKDQ�PHGLFLQH��*HQHVLV&DUH�LV�WKH�8.¶V� leading independent provider of advanced and innovative cancer diagnostics, chemotherapy, radiotherapy, and theragnostics. It currently operates 14 specialist oncology outpatient centres across the UK, including (XURSH¶V�PRVW�DGYDQFHG�UDGLRWKHUDS\�WUHDWPHQW�FHQWUH�DW�&URPZHOO�+RVSLWDO�LQ�/RQGRQ�

*HQHVLV&DUH�SDWLHQWV�FDQ�DFFHVV�3HQQ\�%URKQ�&DQFHU�&DUH¶V�VXSSRUW�YLD�IDFH-to-face services in all 14 of these centres, as well as having access to our digital support. Over 7,700 GenesisCare patients benefited from this support in 2020-2021, with over 70% of patients expressing that the service they received from Penny Brohn Cancer Care had made a positive difference to the way they viewed their health and wellbeing.

The Penny Brohn Cancer Care and GenesisCare partnership is a true example of integrative cancer care in practice, demonstrating the best of clinical, lifestyle and evidence-based supportive therapies coming together to support quality of life and the best possible outcomes for people with cancer.

We are also proud to have partnered with other charities this year including Prostate Cancer Research. We featured as guest experts on a webinar programme offering advice on building resilience, physical activity, coping with advanced disease, and developing wellbeing tools. 350 attendees joined across four sessions, with a further 470 views of recording to date.

Page 5

PENNY BROHN CANCER CARE

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2021

We completed delivery of a mindfulness project via a joint partnership with the National Centre for Integrative Medicine. The project provided a mindfulness based cognitive therapy programme for people living with cancer and supporters and was funded by Macmillan Cancer Support.

We are delighted to have hosted charity partners at our National Centre including Prospect, a support group for prostate cancer patients, their wives, partners, and carers and Bosom Buddies, a Bristol based charity healing patients and families cope with the psychological and everyday effects of breast cancer.

5. Educated healthcare professionals in the benefits of evidence based complementary, lifestyle and holistic approaches to cancer care and support

³,W�LV�PDVVLYHO\�LPSRUWDQW�DQG�HPSRZHULQJ�WR�KDYH�DGGLWLRQDO�WKHUDSLHV�DQG�VXSSRUW�WKDW�DUHQ¶W�OLPLWHG�WR FRQYHQWLRQDO�PHGLFLQH�´

3HQQ\�%URKQ�&DQFHU�&DUH¶V�0HGLFDO�/HDG��'U�&DWKHULQH�=ROOPDQ�FKDLUHG�WKH�%ULWLVK�6RFLHW\�RI�,QWHJUDWLYH� 2QFRORJ\¶V�8.�FRQIHUHQFH��ZLWK�WKUHH�RWKHU�3HQQ\�%URKQ�&DQFHU�&DUH�VWDII�MRLQLQJ�WKH�SDQHO�RI�LQWHUQDWLRQDO� expert speakers. The online conference was attended by 370 healthcare professionals from 27 countries.

We trained the team at PALS Bermuda, a charity supporting people living with cancer in Bermuda, to deliver a wellbeing course using Penny Brohn resources.

We deepened our relationship with the University of Bristol Medical School by offering placements to doctors of the future with the aim of educating them about integrative care and its clinical benefits, not only for cancer but for wider healthcare challenges as well.

We welcomed Joss Walden, a student from the University of Bath who prepared a dissertation, Digitally 'LVFRQQHFWHG��([SORULQJ�6HUYLFH�8VHUV¶�([SHULHQFH�RI�2QOLQH�6XSSRUW�*URXSV�DQG�3HHU�&RQQHFWLRQV ��-RVV¶V� research gave us valuable insight into client experiences of our online services and the peer support they were able to develop within the digital space.

OUR FUTURE PLANS

During 2021, led by CEO Julie Worrall, a working group representing a cross-VHFWLRQ�RI�WKH�&KDULW\¶V�VWDII� team co-created an exciting new organisational strategy for Penny Brohn Cancer Care. We consulted with and listened to the views of people with cancer, clinicians, our partners and supporters to inform its development and set our vision for the future.

Our Vision

Every adult with cancer in the UK is able to access and experience the best of integrative cancer care, leading to better outcomes and quality of life.

Penny Brohn Cancer Care defines integrative cancer care as: Bringing together the best of clinical, lifestyle, and evidence-based supportive therapies.

Whilst clinical interventions directly treat the disease, complementary/lifestyle/supportive therapies can also:

Page 6

PENNY BROHN CANCER CARE

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2021

Our Purpose

What We Believe

Our work will always be underpinned by some fundamental principles and beliefs:

Our Strategic Goals

Delivery of our goals will be supported by a rolling three year implementation roadmap and annual planning process with mid year reviews. We fully expect to need to adapt and course correct as time passes. However, we will continue to be unwavering in the focus on achieving our vision.

THANK YOU

To all those using our services, who generously let us into their lives and who continue to inspire us every day.

We would also like to thank:

The Prince of Wales's Charitable Foundation, The Tim Tiley Bursary Fund, The Gerald Micklem Charitable Trust, The James Tudor Foundation, The Sobell Foundation, The Geoffrey and Pauline Martin Charitable Trust, The Medlock Charitable Trust, The 29th May 1961 Charitable Trust, The Annett Trust, The Anton Jurgens Charitable Trust, Chapman Charitable Trust, Sir Charles Jessel Charitable Trust, The Community Foundation in Wales and Lord Merthyr Fund, Douglas Arter Foundation, The Edward Gostling Foundation, The Elizabeth and Prince Zaiger Trust, The Ernest Kleinwort Charitable Trust, The February Foundation, G M Morrison Charitable Trust, The Gilander Foundation, The Hasluck Charitable Trust, The Hilary Awdry Charitable Trust, The Hospital Saturday Fund, Ian Mactaggart Trust, The Inchcape Foundation, The John Avins Trust, Lillie Johnson Charitable Trust, Nelsons Homeopathic Pharmacy, Pink Ribbon Foundation, The Pople Charitable Trust, Renishaw Charities Committee, The Roger and Douglas Turner Charitable Trust, The Scott Bader Commonwealth Ltd, UKH Foundation, The Uxbridge Charitable Trust, The Walter Guinness Charitable Trust and Webb Family Charitable Trust.

Page 7

PENNY BROHN CANCER CARE

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2021

We would once again like to acknowledge the transformational contributions from the Pilkington Family, the Julia and Hans Rausing Trust and Walk the Walk. At the end of 2020, their support enabled us to begin 2021 on a much stronger footing than forecast.

We would also like to thank:

And finally Penny Brohn UK staff who have continued to work tirelessly through this difficult year to deliver the incredible results we are so proud to share here.

³3HQQ\�%URKQ�KDYH�EHHQ�ZLWK�XV��LQ�RXU�ILJKW�DJDLQVW�FDQFHU��WKURXJKRXW�WKLV�WLPH��7KH\�KDYH�JLYHQ�XV�H[SHUW� advice on a plethora of different areas. They have had a huge impact on how well and happy Manny is - which in turn affects how happy Rabbie and I are. If we only have a year or two left, I want them to be filled with joy and happy memories for our incredible little boy, who loves his daddy. It is now time for us to help Penny Brohn as thH\�KDYH�KHOSHG�XV�´

STRUCTURE, GOVERNANCE AND MANAGEMENT

Penny Brohn UK is the working name of Penny Brohn Cancer Care (the charity) and is a company limited by guarantee, registered on 17 May 1982. It is governed by Memorandum and Articles of Association.

Trustee Board

3HQQ\�%URKQ�&DQFHU�&DUH�LV�JRYHUQHG�E\�D�%RDUG�RI�7UXVWHHV� WKH�%RDUG ��7KH�%RDUG¶V�UHPLW�LV�WR�VHW�WKH� vision, strategy and objectives for the charity in accordance with its objects, to manage the financial resources in the best interest of the charity and its beneficiaries and to ensure the charity operates in a manner consistent with its objectives. The Board met formally six times during 2021, five times remotely and face to face once, (six times remotely in 2020).

The Finance and Audit Committee met three times remotely. The Remuneration and Appointments Committee met twice remotely. The Commercial Committee met four times remotely. Trustee committee members are listed on page 1.

Trustee Appointment, Induction and Training

Trustees are appointed to provide the skills identified as being necessary for the good governance of Penny Brohn Cancer Care. There is a formal recruitment process for identifying new Trustees and once appointed, an induction and training process. The induction of new Trustees is tailored to the needs of the individual but includes the provision of key documents and information relating to the charity, a guided tour of the National Centre, introduction to the Chair, Executive Team and other key staff and an outline of the duties, responsibilities and obligations of being a Trustee. Trustees are encouraged to attend external and internal development events where it is felt these will facilitate the execution of their governance role.

The term of office as a Trustee is a three-year period and Trustees may serve up to three terms, except in exceptional circumstances, when the term of office can be longer. All Trustees give their time voluntarily and receive no remuneration or benefits from the charity. Trustees are required to disclose all relevant interests and register them with the CEO and withdraw from decisions where a potential conflict of interest might arise. Any expenses reclaimed or related party transactions in the year are set out in note 25 to the financial statements.

Page 8

PENNY BROHN CANCER CARE

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2021

Key Management

The Board delegates the day-to-day running of the charity to a Chief Executive Officer and Senior Management Team who report to the Board on a formal, regular basis. The team is wholly comprised of nonstatutory directors namely the CEO, Commercial Director, Services Operations Lead, Financial Controller, Medical Lead and GenesisCare/Penny Brohn Cancer Care Partnership Lead.

Public Benefit

The Trustees of Penny Brohn Cancer Care ensure that the charity carries out its aims and objectives and that these pURYLGH�SXEOLF�EHQHILW��,Q�GRLQJ�VR�WKH�7UXVWHHV�WDNH�LQWR�FRQVLGHUDWLRQ�WKH�&KDULW\�&RPPLVVLRQ¶V� guidance on the Public Benefit requirement under the Charities Act 2011.

Our Charitable Purpose

The charitable objectives of the charity, as set out in the Articles of Association, are to advance health and to relieve sickness and distress, especially but not exclusively in regard to cancer and those affected by it, by such means as the Trustees in their discretion shall decide.

Our vision : Every person with cancer in the UK is able to access and experience the best of integrative cancer care, leading to better outcomes and quality of life.

Our purpose

Pay Policy

The pay and remuneration of the Executive Team is subject to the same structure as used for employees and is in line with the Executive Pay Policy. This policy is regularly reviewed by the Remuneration and Appointments Committee with the support of the Trustee Board. The pay and remuneration of the CEO is reviewed by the Chair (in agreement with the full Trustee Board). There were 48 (2020: 58) full time equivalent employees during the year.

Trading Subsidiary

The charity has a wholly owned trading subsidiary, Shop@PennyBrohn Ltd, which passes all its taxable profit by way of Gift Aid to further the aims of the Charity. Shop@PennyBrohn Ltd has a Board of Directors, which during the year under review consisted of three Trustees and two independent Directors. Penny Brohn Cancer Care owns the entire share capital of the subsidiary.

Risk Management

The Trustees have adopted a risk management strategy which comprises:

Page 9

PENNY BROHN CANCER CARE

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2021

Strategic Risk Register

Strategic risks aUH�VLJQLILFDQW�ULVNV�WKDW�LQIOXHQFH�WKH�DFKLHYHPHQW�RI�WKH�&KDULW\¶V�FRUH�DLPV��7KH\�PLJKW�EH� major internal risks such as financial sustainability or compliance risks. Or they may be external events with high impact which we cannot control and to which we therefore need to respond.

During 2021 key strategic risks were identified as:

Fundraising standards

Penny Brohn Cancer Care is a fully contributing member of the Fundraising Regulator and Institute of Fundraising. We adhere to the Codes of Fundraising Practice in all activity. We are fully compliant with the regulations where it applies to us. We do not contract with third party fundraising organisations or any other commercial participators to raise funds on our behalf. All fundraising activities are organised directly by staff employed by Penny Brohn Cancer Care. We are mindful during our fundraising activities not to be unreasonably persistent or WR�DSSO\�XQGXH�SUHVVXUH�RQ�DQ\RQH�RU�LQWUXGH�RQ�DQ\RQH¶V�SULYDF\��7KH�&KDULW\� did not undertake any telephone, doorstep or lottery fundraising this year. We received no complaints in regards to our fundraising activity and our Safeguarding policy ensures vulnerable adults are protected.

We are committed to best practice in all areas of fundraising activity and are dedicated to delivering transparent, effective, and ethical fundraising. Our supporters are at the heart of our fundraising, and we take our responsibilities to them, and our relationships with them, very seriously.

Staff

We continue to develop strong engagement with our staff team. Our staff have shown remarkable resilience throughout the year as we continued to work remotely during periods of national restrictions. We have implemented measures to ensure staff are supported whilst working from home.

Working with Volunteers

Our volunteers continued to contribute vital support in-person and remotely throughout 2021. Many of our volunteers live with, or support others living with cancer. During 2021, our volunteers continued to work with our data, marketing and fundraising teams. In addition, our team of committed and capable volunteer gardeners kept the gardens at the National Centre looking beautiful and well maintained. We held two events to thank existing volunteers including a socially distanced afternoon tea at the National Centre and a Zoom meeting. We are also developing a new volunteer strategy and will be recruiting volunteers early in 2022 for some exciting new opportunities.

Page 10

PENNY BROHN CANCER CARE

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2021

Clinical governance

Clinical governance refers to assuring the safety and quality of our client facing services which include faceto-face, virtual, remote and online resources. Effective quality assurance enables us to ensure that our services are safe caring, equitable, well-led and responsive to client needs. Penny Brohn Cancer Care has developed a clinical governance framework which ensures that clients receive the best and safest care possible.

In addition, the charity plans to establish a clinical and scientific advisory panel made up of relevant academic and clinical experts from both within and outside of the charity who will provide scrutiny and advice regarding WKH�FOLQLFDO�JRYHUQDQFH�RI�WKH�FKDULW\¶V�VHUYLFes.

FINANCIAL REVIEW

Statement of Financial Affairs (SoFA)

During the year, the Charity received £2.1m in unrestricted income (2020: £2.7m). Restricted income of £185k (2020: £255k) was donated resulting in total income £2.3m (2020: £2.9m).

Major sources of funding were received from:

ajor sources of funding were received from:
2021 2020
£000 £000
Grant makers 300 989
Personal donations 342 456
Legacies 475 222
Community fundraising activities and events 178 140
Strategic partnerships 668 503

£75k was received from from the government as grants under the Coronavirus Job Retention Scheme (CJRS).

Legacy income for the year was £475k and included two significant donations from the estates of clients who used our services many years ago, demonstrating the long-lasting depth of impact our services have had on our clients.

We also received an anonymous donation of £80k from the spouse of a client who we were privileged to support almost 40 years ago.

Income from grant makers included £25k from Walk the Walk, a long-standing supporter and funder of Penny Brohn Cancer Care and the final instalment of £90k from The Prince of Wales Community Fund. We have gratefully received donations from this fund for the past three financial years.

Expenditure in the year was £2.2m (2020: £2.8m). Staff costs were £1.7m (2020: £2 million). They are included gross of the CJRS grant of £75k which is included as other income.

We closed the year with a small surplus of £47k (2020, surplus of £130k). This result is significantly improved on budget due to the generosity of former clients in the form of legacies.

Page 11

PENNY BROHN CANCER CARE

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2021

Balance Sheet

Our National Centre based in Pill, near Bristol, was valued in 2019 at £6.1m. We spent £7k on computer equipment during the year and wrote off £372k of fully depreciated fixtures, fittings and IT equipment.

Consolidated current assets remained at similar levels to 2020 at £1,420k compared to £1,301k in 2020.Cash balances also remained stable at £1m.

Current liabilities reduced to £286k from £296k.

Repayments commenced on the mortgage during 2021, however we also drew down a bounce back loan of £50k in December 2020 which has increased long term liabilities from £944k in 2020 to £947k.

Our closing reserves position is £6.4 million. The funds are itemised below. Our General Fund also known as Free Reserves closed at £979k.

ee Reserves closed at £979k.
����¶V
Capital Fund 5,112
General Fund (Free reserves) 971
Shop@Penny Brohn Ltd 1
Revaluation Reserve 55
Restricted Funds 212

Shop@PennyBrohn Ltd

The trading subsidiary carries out all the trading activities of Penny Brohn Cancer Care. The trading subsidiary manages all room hire and associated services at the National Centre. The former shop opened as D�YLVLWRUV¶�FHQWUH�RIIHULQJ�LQIRUPDWLRQ�WR�FOLHnts as well as selling goods such as books, nutrition items and body care products. Trading activity during 2021 was £65k (2020: £76k). Shop @ Penny Brohn Ltd did not generate sufficient profits during 2021 to enable a donation to be made under deed of covenant to Penny Brohn Cancer Care (2020: £2k).

Reserves policy

Group reserves on 30 November 2021 amounted to £6.3m (2020: £6.3m) of which £5.1m related to the capital fund (2020: £5.2m). £212k are restricted funds (2020: £186k). Restricted funds are itemised in note 20 of the financial statements. Penny Brohn free reserves have increased from £878k in 2020 to £971k. The LQFUHDVH�LV�GXH�WKH�JHQHURVLW\�RI�VRPH�JUDQW�IXQGHUV�ZKR�SHUPLWWHG�WKH�&KDULW\�WR�³GHUHVWULFW´�IXQGV�EHFDXVH� of the pandemic and transfer the funds to core. These funds were primarily used to fund our remote service provision during 2020 and 2021.

The Trustees consider that free reserves of two months expenditure are desirable which amounts to £500k based on 2022 budgeted expenditure. A higher level of free reserves was achieved in 2021. However, this does give us a contingency for the continued uncertainty in the coming financial year as the pandemic continues. It also enables us to make investments to advance our new strategy. Our current year budget incorporates an assumption that we will continue to achieve reserves of £500k during the financial year 2021/22.

Going Concern

The Finance and Audit Committee regularly review financial reports from the Charity, including forecast cash flow VFHQDULRV��WR�DWWHVW�SRVLWLYHO\�WR�WKH�&KDULW\¶V�JRLQJ�FRQFHUQ�VWDWXV��7KLV�UHYLHZ�LV�VKDUHG�ZLWK�WKH�IXOO� Trustee Board at each Trustee meeting.

The charity has two committed loan facilities, both secured on the National Centre: A mortgage of £1m with NatWest Bank. The mortgage has a ten year term and an interest rate of 3.42%. The Charity also has revolving loan facilities of up to £500k with Triodos Bank and £500k with NatWest. Neither was utilised during the year. We have excellent business relationships with NatWest and Triodos.

The Charity intends to continue holding these term debt facilities to bridge timing gaps in revenue raising.

Page 12

PENNY BROHN CANCER CARE

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2021

The charity drew down a £50,000 Bounce Back Loan in December 2020, to aid cash flow over the winter of 2020/21. The loan has a five year term and an interest rate of 2.5%. The loan is 100% guaranteed by the Government and repayments commenced in December 2021.

The Trustees have a structured approach to the financial strategy of the charity, which includes a three -year plan reviewed by Trustees annually from which the 12-month budget and cash flow forecast is prepared. Quarterly forecasts are also prepared. The Trustees review and monitor the budget and cash flows at each Trustees meeting, interrogating variances. This continuous monitoring and control ensure the Trustees can SURSHUO\�UHYLHZ�WKH�FKDULW\¶V�JRLQJ�FRQFHUQ�VWDWXV�DQG�LWV�ILQDQFLDO�YLDELOLW\���

7KH�7UXVWHHV�UHYLHZ�WKH�FKDULW\¶V�IRUHFDVWV�DQG�SURMHFWLRQV�DW�HDFK�%RDUG�PHHWLQJ�DQG�KDYH�D�UHDVRQDEOH� expectation that the charity has adequate resources to continue in operational existence for a period of at least 12 months following the date of approval of these financial statements. The group therefore continues to adopt the going concern basis for preparing its consolidated financial statements.

Disclosure of information to the auditors

In so far as the Trustees are aware:

Approved by order of the members of the Board of Trustees and signed on their behalf, by:

Stephen Rosser Chair

Date: 8 April 2022

Page 13

PENNY BROHN CANCER CARE

STATEMENT OF TRUSTEES' RESPONSIBILITIES FOR THE YEAR ENDED 30 NOVEMBER 2021

The Trustees (who are also the directors of the Charity for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial . Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Group and the Charity and of their incoming resources and application of resources, including their income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Group and the Charity's transactions and disclose with reasonable accuracy at any time the financial position of the Group and the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Group and the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Approved by order of the members of the Board of Trustees and signed on its behalf by:

Stephen Rosser Chair Date: 8 April 2022

Page 14

PENNY BROHN CANCER CARE

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF PENNY BROHN CANCER CARE

OPINION

We have audited the financial statements of Penny Brohn Cancer Care (the 'parent charitable company') and its subsidiaries (the 'group') for the year ended 30 November 2021 which comprise the Consolidated Statement of Financial Activities, the Consolidated Balance Sheet, the Charity Balance Sheet, the Consolidated Statement of Cash Flows and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

BASIS FOR OPINION

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

CONCLUSIONS RELATING TO GOING CONCERN

In auditing the financial statements, we have concluded that the Trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the parent charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.

OTHER INFORMATION

The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' Report thereon. The Trustees are responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Page 15

PENNY BROHN CANCER CARE

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF PENNY BROHN CANCER CARE (CONTINUED)

OPINION ON OTHER MATTERS PRESCRIBED BY THE COMPANIES ACT 2006

In our opinion, based on the work undertaken in the course of the audit:

MATTERS ON WHICH WE ARE REQUIRED TO REPORT BY EXCEPTION

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees' Report.

We have nothing to report in respect of the following matters in relation to which Companies Act 2006 requires us to report to you if, in our opinion:

RESPONSIBILITIES OF TRUSTEES

As explained more fully in the Trustees' Responsibilities Statement, the Trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the Trustees are responsible for assessing the Group's and the parent charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the Group or the parent charitable company or to cease operations, or have no realistic alternative but to do so.

Page 16

PENNY BROHN CANCER CARE

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF PENNY BROHN CANCER CARE (CONTINUED)

AUDITORS' RESPONSIBILITIES FOR THE AUDIT OF THE FINANCIAL STATEMENTS

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

As a result of these procedures, we have considered the opportunities and incentives that may exist within the organisation for fraud and identified the highest area of risk to be in relation to revenue recognition, with a particular risk in relation to year-end cut off. In common with all audits under ISAs (UK) we are also required to perform specific procedures to respond to the risk of management override. We have also obtained understanding of the legal and regulatory frameworks that the company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included the UK Companies Act, FRS 102 and UK tax legislation. In addition, we considered the provisions of other laws and regulations that do no have a direct effect on the financial statements but compliance with which may be fundamental to the Company's ability to operate or avoid a material penalty.

Our procedures to respond to risks identified included the following:

We also communicated identified laws and regulations and potential fraud risks to all members of the engagement team and remained alert to possible indicators of fraud or non-compliance with laws and regulations throughout the audit.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

Page 17

PENNY BROHN CANCER CARE

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF PENNY BROHN CANCER CARE (CONTINUED)

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' Report.

USE OF OUR REPORT

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an Auditors' Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and its members, as a body, for our audit work, for this report, or for the opinions we have formed.

David Butler FCA DChA (Senior statutory auditor)

for and on behalf of

Bishop Fleming LLP Chartered Accountants Statutory Auditors 10 Temple Back Bristol BS1 6FL

8 April 2022

Page 18

PENNY BROHN CANCER CARE

CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 30 NOVEMBER 2021

Note
INCOME FROM:
Donations and legacies
4
Charitable activities
5
Other trading activities
6
Other income
7
TOTAL INCOME
EXPENDITURE ON:
Raising funds
8
Charitable activities
TOTAL EXPENDITURE
NET (EXPENDITURE)/INCOME
Transfers between funds
21
NET MOVEMENT IN FUNDS
RECONCILIATION OF FUNDS:
Total funds brought forward
Net movement in funds
TOTAL FUNDS CARRIED FORWARD		 Unrestricted
funds
2021
£000
1,175
702
148
75
2,100
393
1,789
2,182
(82)
103
21
6,150
21
6,171		 Restricted
funds
2021
£000
185
-
-
-
185
-
56
56
129
(103)
26
186
26
212		 Total
funds
2021
£000
1,360
702
148
75
2,285
393
1,845
2,238
47
-
47
6,336
47
6,383		 Total
funds
2020
£000
1,808
536
111
475
2,930
499
2,303
2,802
128
-
128
6,208
128
6,336

The Consolidated Statement of Financial Activities includes all gains and losses recognised in the year.

The notes on pages 23 to 43 form part of these financial statements.

Page 19

PENNY BROHN CANCER CARE REGISTERED NUMBER:01635916

CONSOLIDATED BALANCE SHEET AS AT 30 NOVEMBER 2021

Note
FIXED ASSETS
Intangible assets
13
Tangible assets
14
Investments
15
CURRENT ASSETS
Stocks
16
Debtors
17
Cash at bank and in hand
Creditors: amounts falling due within one
year
18
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT
LIABILITIES
Creditors: amounts falling due after more
than one year
19
TOTAL NET ASSETS
CHARITY FUNDS
Restricted funds
21
Unrestricted funds
21
TOTAL FUNDS		 21
356
1,075
1,452
(286)		 2021
£000
46
6,111
7
6,164
1,166
7,330
(947)
6,383
212
6,171
6,383		 13
208
1,080
1,301
(296)		 2020
£000
63
6,205
7
6,275
1,005
7,280
(944)
6,336
186
6,150
6,336

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:

Stephen Rosser Chair

Ken Guy Trustee

Date: 8 April 2022

The notes on pages 23 to 43 form part of these financial statements.

Page 20

PENNY BROHN CANCER CARE REGISTERED NUMBER:01635916

CHARITY STATEMENT OF FINANCIAL POSITION FOR THE YEAR ENDED 30 NOVEMBER 2021

Note
FIXED ASSETS
Intangible assets
13
Tangible assets
14
Investments
15
CURRENT ASSETS
Debtors
17
Cash at bank and in hand
Creditors: amounts falling due within one
year
18
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT
LIABILITIES
Creditors: amounts falling due after more
than one year
19
TOTAL NET ASSETS
CHARITY FUNDS
Restricted funds
21
Unrestricted funds
21
TOTAL FUNDS		 378
1,062
1,440
(275)		 2021
£000
46
6,111
7
6,164
1,165
7,329
(947)
6,382
212
6,170
6,382		 249
1,001
1,250
(248)		 2020
£000
63
6,205
7
6,275
1,002
7,277
(944)
6,333
186
6,147
6,333

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:

Stephen Rosser Chair

Ken Guy Trustee

Date: 8 April 2022

The notes on pages 23 to 43 form part of these financial statements.

Page 21

PENNY BROHN CANCER CARE

CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 30 NOVEMBER 2021

CASH FLOWS FROM OPERATING ACTIVITIES
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of tangible fixed assets
NET CASH USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Cash inflows from new borrowing
Repayments of borrowing
Interest Paid
NET CASH (USED IN)/PROVIDED BY FINANCING ACTIVITIES
CHANGE IN CASH AND CASH EQUIVALENTS IN THE YEAR
Cash and cash equivalents at the beginning of the year
CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR
The notes on pages 23 to 43 form part of these financial statements		 2021
£000
9
(8)
(8)
50
(31)
(25)
(6)
(5)
1,080
1,075		 2020
£000
383
(136)
(136)
1,000
(600)
-
400
647
433
1,080

Page 22

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

1. GENERAL INFORMATION

Penny Brohn Cancer Care is a charity registered in England and Wales and a company limited by guarantee. It was incorporated on 17 May 1982 (company number 01635916) and registered as a charity on 30 June 1982 (charity number 284881). Penny Brohn UK is the working name of Penny Brohn Cancer Care.

The company was established under a Memorandum of Association which established the objects and powers of the charitable company and is governed under its Articles of Association.

2. ACCOUNTING POLICIES

2.1 BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Penny Brohn Cancer Care meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

The Consolidated Statement of Financial Activities (SOFA) and Consolidated Balance Sheet consolidate the financial statements of the Charity and its subsidiary undertaking. The results of the subsidiary are consolidated on a line by line basis.

The Charity has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of Financial Activities in these financial statements.

2.2 GOING CONCERN

The Charity's forecasts and projections show that the Charity expects to operate within the level of its current debt facility. As detailed in the annual report, the Charity seeks to increase income from fundraising to enable more people to access free support to help them live well with cancer, and allow us to influence the healthcare agenda.

The Finance & Audit Committee regularly review various relevant financial reports from the Charity, including forecast cash flow scenarios, to attest positively to the Charity's going concern status. This review is shared with the full Trustee Board at each Trustee meeting.

The Charity has two committed loan facilities. It plans to continue to hold these term debt facilities, secured on the National Centre, that are used to bridge timing gaps in revenue raising.

The Charity received a £50,000 Bounceback loan in December 2020. The loan is 100% guaranteed by the Government repayments commenced in December 2021.

Page 23

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

2. ACCOUNTING POLICIES (continued)

2.2 GOING CONCERN (CONTINUED)

The Trustees have a structured approach to the financial strategy of the Charity, which includes the 5 year plan reviewed by Trustees annually from which the 12 month budget and cash flow forecast is prepared. Quarterly forecasts are also prepared. Trustees review and monitor the budget and cash flows at each Trustees meeting, interrogating variances. This continuous monitoring and control ensures the Trustees are able to properly review the Charity’s going concern status and its financial viability. The Trustees review the Charity’s forecasts and projections at each Board meeting and have a reasonable expectation that the Charity has adequate resources to continue in operational existence for a period of at least 12 months following the date of approval of these financial statements. The Group therefore continues to adopt the going concern basis for preparing its consolidated financial statements.

2.3 INCOME

All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

The recognition of income from legacies is dependent on establishing entitlement, the probability of receipt and the ability to estimate with sufficient accuracy the amount receivable. Evidence of entitlement to a legacy exists when the Charity has sufficient evidence that a gift has been left to them (through knowledge of the existence of a valid will and the death of the benefactor) and the executor is satisfied that the property in question will not be required to satisfy claims in the estate. Receipt of a legacy must be recognised when it is probable that it will be received and the fair value of the amount receivable, which will generally be the expected cash amount to be distributed to the Charity, can be reliably measured.

Other income is recognised in the period in which it is receivable and to the extent the goods have been provided or on completion of the service.

2.4 EXPENDITURE

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Expenditure on raising funds includes all expenditure incurred by the Group to raise funds for its charitable purposes and includes costs of all fundraising activities events and non-charitable trading.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Group's objectives, as well as any associated support costs.

All expenditure is inclusive of irrecoverable VAT.

Page 24

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

2. ACCOUNTING POLICIES (continued)

2.5 INTANGIBLE ASSETS AND AMORTISATION

Intangible assets costing £500 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Amortisation is provided on the following bases:

Website - 25 %
Computer software - 20 %

2.6 TANGIBLE FIXED ASSETS AND DEPRECIATION

Tangible fixed assets costing £500 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Freehold property - 2%
Long-term leasehold property - based upon the length of the lease
Fixtures and fittings - 10%
Computer equipment - 20%

2.7 INVESTMENTS

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance Sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Consolidated Statement of Financial Activities.

2.8 STOCKS

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.

2.9 DEBTORS

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

Page 25

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

2. ACCOUNTING POLICIES (continued)

2.10 CASH AT BANK AND IN HAND

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

2.11 LIABILITIES AND PROVISIONS

Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Consolidated Statement of Financial Activities as a finance cost.

2.12 FINANCIAL INSTRUMENTS

The Group only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

2.13 PENSIONS

The Group operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Group to the fund in respect of the year.

2.14 FUND ACCOUNTING

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Group and which have not been designated for other purposes.

Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Group for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

Page 26

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

3. CRITICAL ACCOUNTING ESTIMATES AND AREAS OF JUDGEMENT

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Critical accounting estimates and assumptions:

The Group makes estimates and assumptions concerning the future. The resulting accounting estimates and assumptions will, by definition, seldom equal the related actual results. The Group do not consider there to be estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities.

Page 27

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

4. INCOME FROM DONATIONS AND LEGACIES

Unrestricted
funds
2021
Restricted
funds
2021
£000
£000
DONATIONS
General donations
640
185
Donations from the Friends of Penny Brohn
Cancer Care
60
-
Legacies
475
-
1,175
185
TOTAL 2020
1,553
255
5.
INCOME FROM CHARITABLE ACTIVITIES
Unrestricted
funds
2021
£000
Service generated income from partnerships
672
Service generated income from NHS
28
Service generated income from training
2
Management recharges
-
702		 Total
funds
2021
£000
825
60
475
1,360
1,808
Total
funds
2021
£000
672
28
2
-
702		 Total
funds
2020
£000
1,527
59
222
1,808
Total
funds
2020
£000
483
20
-
33
536

Page 28

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

6. INCOME FROM OTHER TRADING ACTIVITIES

Income from fundraising events

Unrestricted
funds
2021
£000
Facilities income
12
The Hub
71
83
Income from non charitable trading activities
Unrestricted
funds
2021
£000
Shop@PennyBrohn Income
65
7.
OTHER INCOMING RESOURCES
Unrestricted
funds
2021
£000
CJRS recovery grant
75		 Total
funds
2021
£000
12
71
83
Total
funds
2021
£000
65
Total
funds
2021
£000
75		 Total
funds
2020
£000
26
9
35
Total
funds
2020
£000
76
Total
funds
2020
£000
475

Page 29

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

8. EXPENDITURE ON RAISING FUNDS

FUNDRAISING TRADING EXPENSES

Unrestricted
funds
2021
£000
Fundraising
72
Shop@PennyBrohn Ltd
38
The Hub
31
Wages and salaries
241
Pension costs
11
393
9.
ANALYSIS OF CHARITABLE ACTIVITIES
Activities
undertaken
directly
2021
£000
Face to Face and Remote Service delivery
807
Adminstration
563
Communications
116
Partnerships
106
Facilities
253
1,845
10.
AUDITORS' REMUNERATION
Fees payable to the Charity's auditor for the audit of the Charity's annual
accounts		 Total
funds
2021
£000
72
38
31
241
11
393
Total
funds
2021
£000
807
563
116
106
253
1,845
2021
£000
13		 Total
funds
2020
£000
65
74
40
304
16
499
Total
funds
2020
£000
974
736
102
101
390
2,303
2020
£000
13

Page 30

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

11. STAFF COSTS

Wages and salaries
Social security costs
Contribution to defined contribution pension
schemes		 Group
2021
£000
1,411
103
68
1,582		 Group
2020
£000
1,709
128
87
1,924		 Charity
2021
£000
1,411
103
68
1,582		 Charity
2020
£000
1,710
128
87
1,925

Redundancy costs in the year amounted to £5,932 (2020: £77,125).

The average number of persons employed by the Charity during the year was as follows:

Staff
The average headcount expressed as full-time equivalents was:
Delivery of face to face and remote client services
Fundraising and trading
Finance and administration
Facilities
The Hub		 Group
2021
No.
87
Group
2021
No.
26
5
9
6
2
48		 Group
2020
No.
113
Group
2020
No.
28
8
10
11
1
58

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:

Group Group
2021 2020
No. No.
In the band £60,001 - £70,000 1 -
In the band £70,001 - £80,000 1 -

The key management personnel of the group and parent charity comprise the Trustees, the CEO, Commercial Director, Financial Controller and Services Operations Lead and Genesis Care/Penny Brohn Partnership Lead. The total employee benefits of the key management personnel of the charity for the year was £302,770 (2020: £271,104), including social security costs of £29,493 (2020: £25,061).

Page 31

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

12. TRUSTEES' REMUNERATION AND EXPENSES

During the year, no Trustees received any remuneration or other benefits (2020 - £NIL).

During the year ended 30 November 2021, expenses totalling £53.90 were reimbursed to 1 Trustee (2020 - £NIL).

13. INTANGIBLE ASSETS

GROUP AND CHARITY

COST
At 1 December 2020
At 30 November 2021
AMORTISATION
At 1 December 2020
Charge for the year
At 30 November 2021
NET BOOK VALUE
At 30 November 2021
At 30 November 2020		 Patents
£000
39
39
39
-
39
-
-		 Computer
software
£000
86
86
23
17
40
46
63		 Total
£000
125
125
62
17
79
46
63

Page 32

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

14. TANGIBLE FIXED ASSETS

GROUP AND CHARITY

COST OR VALUATION
At 1 December 2020
Additions
Disposals
At 30 November 2021
DEPRECIATION
At 1 December 2020
Charge for the year
On disposals
At 30 November 2021
NET BOOK VALUE
At 30 November 2021
At 30 November 2020		 Freehold
property
£000
6,424
-
-
6,424
396
73
-
469
5,955
6,028		 Long-term
leasehold
property
£000
118
-
-
118
12
12
-
24
94
106		 Fixtures and
fittings
£000
382
1
(306)
77
337
6
(306)
37
40
45		 Computer
equipment
£000
122
7
(66)
63
96
11
(66)
41
22
26		 Total
£000
7,046
8
(372)
6,682
841
102
(372)
571
6,111
6,205

It is Penny Brohn Cancer Care's policy to revalue freehold property every 5 years. The freehold property was revalued in August 2019 by Jones Lang LaSalle Limited, a firm of valuers external to the Charity. The property's open market value was considered to be £6,100,000 in accordance with the RICS valuation model.

The carrying amount under the cost model of the assets which have been revalued would have been £6,045,000 (2020 - £6,045,000).

Page 33

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

15. FIXED ASSET INVESTMENTS

GROUP AND CHARITY
COST OR VALUATION
At 1 December 2020
At 30 November 2021
NET BOOK VALUE
At 30 November 2021
At 30 November 2020		 Listed
investments
£000
7
7
7
7

16. STOCKS

Group Group
2021 2020
£000 £000
Finished goods and goods for resale 21 13

17. DEBTORS

DUE WITHIN ONE YEAR
Trade debtors
Amounts owed by group undertakings
Other debtors
Prepayments and accrued income		 Group
2021
£000
194
-
7
155
356		 Group
2020
£000
113
-
1
94
208		 Charity
2021
£000
188
28
7
155
378		 Charity
2020
£000
111
44
1
93
249

Page 34

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

18. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Bank loans
Trade creditors
Other taxation and social security
Other creditors
Accruals and deferred income		 Group
2021
£000
72
78
28
16
92
286		 Group
2020
£000
56
57
31
14
138
296		 Charity
2021
£000
72
71
27
14
91
275		 Charity
2020
£000
56
55
31
14
92
248

Facilities with NatWest Bank and Triodos Bank, secured on the freehold property of the Charity, are in place.

Deferred income at 1 December 2020
Resources deferred during the year
Amounts released from previous periods		 Group
2021
£000
19
41
(19)
41		 Group
2020
£000
7
19
(7)
19

19. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

Bank loans
Other loans		 Group
2021
£000
908
39
947		 Group
2020
£000
944
-
944		 Charity
2021
£000
908
39
947		 Charity
2020
£000
944
-
944

The aggregate amount of liabilities payable or repayable wholly or in part more than five years after the reporting date is:

Payable or repayable by instalments Group
2021
£000
664
664		 Group
2020
£000
700
700		 Charity
2021
£000
664
664		 Charity
2020
£000
700
700

Page 35

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

20. FINANCIAL INSTRUMENTS

FINANCIAL ASSETS
Financial assets measured at amortised cost
FINANCIAL LIABILITIES
Financial liabilities measured at amortised
cost		 Group
2021
£000
1,399
Group
2021
£000
1,233		 Group
2020
£000
1,288
Group
2020
£000
1,240		 Charity
2021
£000
1,408
Charity
2021
£000
1,222		 Charity
2020
£000
1,250
Charity
2020
£000
1,192

Financial assets measured at amortised cost is comprised of cash at bank and in hand and debtors.

Financial liabilites measured at amortised cost is comprised of creditors.

Page 36

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

21. STATEMENT OF FUNDS

STATEMENT OF FUNDS - CURRENT YEAR

Balance at 1
December 2020
£000
UNRESTRICTED FUNDS
DESIGNATED FUNDS
Capital fund
5,213
GENERAL FUNDS
General fund
878
Shop@Penny Brohn Ltd
4
Revaluation reserve
55
TOTAL GENERAL FUNDS
937
TOTAL UNRESTRICTED FUNDS
6,150
RESTRICTED FUNDS
Tim Tiley Bursary fund
3
Living Well programme
20
Treatment support
-
Digital Discovery
-
Relaxation chairs
5
Garden
7
Nutrition at Penny Brohn
-
Buildings at National Centre
4
Bristol Whole Life Approach in Scotland
13
Living Well - National
2
Community engagement
80
Pre-treatment support clinic at BHOC
9
Remote services
-
Penny Brohn on the High Street
40
Trust income
2
Other small donations
1
Restricted to Client Insight
-
One to One
-
TOTAL UNRESTRICTED FUNDS
186
TOTAL OF FUNDS
6,336		 Balance at 1
December 2020
£000
UNRESTRICTED FUNDS
DESIGNATED FUNDS
Capital fund
5,213
GENERAL FUNDS
General fund
878
Shop@Penny Brohn Ltd
4
Revaluation reserve
55
TOTAL GENERAL FUNDS
937
TOTAL UNRESTRICTED FUNDS
6,150
RESTRICTED FUNDS
Tim Tiley Bursary fund
3
Living Well programme
20
Treatment support
-
Digital Discovery
-
Relaxation chairs
5
Garden
7
Nutrition at Penny Brohn
-
Buildings at National Centre
4
Bristol Whole Life Approach in Scotland
13
Living Well - National
2
Community engagement
80
Pre-treatment support clinic at BHOC
9
Remote services
-
Penny Brohn on the High Street
40
Trust income
2
Other small donations
1
Restricted to Client Insight
-
One to One
-
TOTAL UNRESTRICTED FUNDS
186
TOTAL OF FUNDS
6,336		 Balance at 1
December 2020
£000
UNRESTRICTED FUNDS
DESIGNATED FUNDS
Capital fund
5,213
GENERAL FUNDS
General fund
878
Shop@Penny Brohn Ltd
4
Revaluation reserve
55
TOTAL GENERAL FUNDS
937
TOTAL UNRESTRICTED FUNDS
6,150
RESTRICTED FUNDS
Tim Tiley Bursary fund
3
Living Well programme
20
Treatment support
-
Digital Discovery
-
Relaxation chairs
5
Garden
7
Nutrition at Penny Brohn
-
Buildings at National Centre
4
Bristol Whole Life Approach in Scotland
13
Living Well - National
2
Community engagement
80
Pre-treatment support clinic at BHOC
9
Remote services
-
Penny Brohn on the High Street
40
Trust income
2
Other small donations
1
Restricted to Client Insight
-
One to One
-
TOTAL UNRESTRICTED FUNDS
186
TOTAL OF FUNDS
6,336		 Income
£000
-
2,035
65
-
2,100
2,100
-
-
2
-
-
-
15
2
-
14
100
-
47
-
-
-
-
5
185
2,285		 Expenditure
£000
(101)
(2,013)
(68)
-
(2,081)
(2,182)
-
-
(1)
(12)
-
-
(11)
(1)
(1)
-
(3)
(9)
(8)
(5)
-
-
-
(5)
(56)
(2,238)		 Transfers
in/out
£000
Balance at 30
November 2021
£000
-
5,112
103
1,003
-
1
-
55
103
1,059
103
6,171
(3)
-
-
20
-
1
12
-
-
5
-
7
-
4
-
5
-
12
-
16
(127)
50
-
-
-
39
(10)
25
-
2
-
1
25
25
-
-
(103)
212
-
6,383
878
4
55
937
6,150
3
20
-
-
5
7
-
4
13
2
80
9
-
40
2
1
-
-
186
6,336

Page 37

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

21. STATEMENT OF FUNDS (CONTINUED)

Capital Fund

The capital fund represents the net book value of fixed assets, less loans secured on the freehold property plus the revaluation reserve.

Transfers between funds are as follows:

a) £103k transferred between the restricted and the unrestricted funds b) £27k of funds reallocated between restricted funds

Restricted funds

Tim Tiley Bursary Fund

The Bursary fund is used to help fund our digital services and to subsidise travel to the National Centre.

Restricted to Living Well National Centre

The Living Well programme fund is to enable us to carry out Living Well courses at our National Centre and regionally.

Restricted to Treatment Support

The Treatment Support fund contains donations to cover the cost of providing Treatment Support Clinic online was supported by grants the Sir Jules Thorn Charitable Trust and the Douglas Arter Foundation during 2021.

Digital Discovery

Penny Brohn UK is working with Lightful to improve our digital systems and processes.

Restricted to Relaxation Chairs

The Relaxation chairs fund is a grant to enable us to upgrade and replace our relaxation chairs.

Restricted to Garden/NGS

The garden is maintained by a dedicated group of volunteers and brings peace and enjoyment to all visitors to the National Centre.

Restricted to Nutrition

Our Nutritional programme offers advice on making realistic and sustainable lifestyle changes to support healthy eating. Our programme includes cookery demonstrations, healthy eating days and , nutritional therapy. Funds were received from The James Tudor Foundation and the Sir Charles Jessel Charitable Trust during 2021.

Restricted to Building expenditure at Penny Brohn’s National Centre

Funds were received from the Postcode Local Trust to help make the National Centre ‘COVID-safe’ as we begin the process of opening it back up—first for commercial venue hire, and subsequently for cancer clients as soon as Government guidance indicates it is safe to do so.

Funds were received from the Green Hall Foundation to improve disabled access through the installation of automatic doors at the National Centre (NC).

Dumfries House - Scotland Partnership

The Bristol Whole Life Approach in Scotland is a pilot project to work in partnership with Dumfries House in Ayrshire, giving us the chance to take our Bristol Whole Life Approach to men and women living with cancer in Scotland.

Restricted to Living Well South Coast

Funding received from The Gerald Micklem Charitable Trust to deliver three Living Well courses on the South Coast, as well as investment into a new regional strategic partnership model. This funding was ultimately repurposed, with approval from the funder, to support our remote services programme.

Page 38

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

21. STATEMENT OF FUNDS (CONTINUED)

Restricted to Living Well Isle of Wight

To support Isle of Wight residents to attend national centre for LW course and Applegate Breast Cancer Support Group to attend "Food to lift the spirits" course. Four Isle of Wight residents attended LW course at NC.

Restricted to Living Well The Midlands

To support residents of Wiltshire to access our services.

Restricted to Living Well Wiltshire

To support residents of Wiltshire to access our services.

Restricted to Bristol Community Engagement

Community based health and wellbeing services offer an outstanding opportunity to access deprived communities most in need of our help, before their condition has reached late stage. Our community engagement project is supported by The Princes Trust and The Medlock Charitable Trust.

Pre Treatment Support at BHOC

Funds were received from Friends of BHOC (Bristol Haematology & Oncology Centre) towards the salary costs of our Health Care Engagement & Community Development Lead, who spends two and a half days at the BHOC Chemotherapy Day Unit; as well as funding for our Treatment Support Clinic and one-to-one counselling services.

Restricted to Remote Services

A programme of online support with national reach, for people affected by cancer who have been isolated due to the COVID-19 pandemic. We have moved from face to face to remote services from April 2020 and the funds provided have supported that transition.

Restricted to Penny Brohn on the High Street

Penny Brohn on the High Street intends to return to a central Bristol location to permanently embed our services in the heart of the Bristol community. We aim to build visibility within communities by creating a high street destination offering Living Well services and self-management resources alongside the more traditional donated goods shop model.

Page 39

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

21. STATEMENT OF FUNDS (CONTINUED)

STATEMENT OF FUNDS - PRIOR YEAR

UNRESTRICTED FUNDS
DESIGNATED FUNDS
Capital fund
GENERAL FUNDS
General fund
Shop@Penny Brohn Ltd
Revaluation reserve
TOTAL GENERAL FUNDS
TOTAL UNRESTRICTED FUNDS
RESTRICTED FUNDS
Tim Tiley Bursary fund
Living Well programme
Treatment Support Clinic
Relaxation chairs
Garden
Nutrition at Penny Brohn
Buildings at National Centre
Bristol Whole Life Approach in
Scotland
Living Well - National
Community Engagement
Pre-treatment support clinic at BHOC
Remote Services
Penny Brohn on the High Street
Trust income
Other small donations
TOTAL RESTRICTED FUNDS
TOTAL OF FUNDS		 Balance at
1 December
2019
£000
Income
£000
5,600
-
261
2,600
4
76
55
-
320
2,676
5,920
2,676
2
1
20
1
-
6
5
-
2
7
-
10
-
13
16
-
2
12
37
80
1
12
-
56
203
50
-
3
-
4
288
255
6,208
2,931		 Expenditure
£000
(122)
(2,248)
(76)
-
(2,324)
(2,446)
-
(1)
(6)
-
(2)
(10)
(9)
(3)
(12)
(37)
(4)
(56)
(213)
(1)
(3)
(357)
(2,803)		 Transfers
in/out
£000
Balance at
30 November
2020
£000
(265)
5,213
265
878
-
4
-
55
265
937
-
6,150
-
3
-
20
-
-
-
5
-
7
-
-
-
4
-
13
-
2
-
80
-
9
-
-
-
40
-
2
-
1
-
186
-
6,336		 Transfers
in/out
£000
Balance at
30 November
2020
£000
(265)
5,213
265
878
-
4
-
55
265
937
-
6,150
-
3
-
20
-
-
-
5
-
7
-
-
-
4
-
13
-
2
-
80
-
9
-
-
-
40
-
2
-
1
-
186
-
6,336
878
4
55
937
6,150
3
20
-
5
7
-
4
13
2
80
9
-
40
2
1
186
6,336

Page 40

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

22. ANALYSIS OF NET ASSETS BETWEEN FUNDS ANALYSIS OF NET ASSETS BETWEEN FUNDS - CURRENT YEAR

Unrestricted
funds
2021
£000
Tangible fixed assets
6,111
Intangible fixed assets
46
Fixed asset investments
7
Current assets
1,240
Creditors due within one year
(286)
Creditors due in more than one year
(947)
TOTAL
6,171
ANALYSIS OF NET ASSETS BETWEEN FUNDS - PRIOR YEAR
Unrestricted
funds
2020
£000
Tangible fixed assets
6,205
Intangible fixed assets
63
Fixed asset investments
7
Current assets
1,115
Creditors due within one year
(296)
Creditors due in more than one year
(944)
TOTAL
6,150		 Restricted
funds
2021
£000
-
-
-
212
-
-
212
Restricted
funds
2020
£000
-
-
-
186
-
-
186		 Total
funds
2021
£000
6,111
46
7
1,452
(286)
(947)
6,383
Total
funds
2020
£000
6,205
63
7
1,301
(296)
(944)
6,336
Tangible fixed assets
Intangible fixed assets
Fixed asset investments
Current assets
Creditors due within one year
Creditors due in more than one year
TOTAL

Page 41

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

23.
RECONCILIATION OF NET MOVEMENT IN FUNDS TO NET CASH FLOW
ACTIVITIES
Net income for the year (as per Statement of Financial Activities)
ADJUSTMENTS FOR:
Depreciation charges
Amortisation charges
Decrease/(increase) in stocks
Decrease/(increase) in debtors
Increase/(decrease) in creditors
Interest paid
NET CASH PROVIDED BY OPERATING ACTIVITIES
24.
ANALYSIS OF CASH AND CASH EQUIVALENTS
Cash in hand
TOTAL CASH AND CASH EQUIVALENTS
25.
ANALYSIS OF CHANGES IN NET FUNDS
At 1
December
2020
£000
Cash at bank and in hand
1,080
Debt due within 1 year
(56)
Debt due after 1 year
(944)
80		 FROM OPERATING
Group
Group
2021
2020
£000
£000
47
128
102
100
17
22
(8)
3
(116)
65
(26)
63
25
-
41
381
Group
Group
2021
2020
£000
£000
1,075
1,080
1,075
1,080
Cash flows
At 30
November
2021
£000
£000
(5)
1,075
(16)
(72)
(3)
(947)
(24)
56

Page 42

PENNY BROHN CANCER CARE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2021

26. RELATED PARTY TRANSACTIONS

Trustees' remuneration and expenses is detailed in note 12.

Trustees are able to make use of the accomodation at the National Centre when attending on business and usually provide a donation in respect of this. No Trustees were provided any nights accomodation the year (2020: nil).

Donations from trustees and related parties amounted to £2,170 during the year (2020: £7,440).

Page 43